This inventor holds 5 USPTO granted patents. Top assignees: Celtrix Pharmaceuticals, Inc., Genzyme Corporation, Other. Active years: 1996-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 45 
1 out of 825 
1 out of 834,513 Years Active: 1996-2002
Title: The Innovative Contributions of Wendy O Waegell
Introduction
Wendy O Waegell is a prominent inventor based in Mountain View, CA, known for her significant contributions to the field of biotechnology. With a total of five patents to her name, she has made remarkable advancements in the development of monoclonal antibodies.
Latest Patents
Wendy's latest patents focus on monoclonal antibodies to transforming growth factor-beta (TGF-B). These antibodies are prepared from hybrid cell lines by immunizing with TGF-B2. The antibodies can be of any isotype and may originate from various mammalian sources, including murine or human. Additionally, therapeutic applications utilizing the TGF-B monoclonal antibody are disclosed in her patents.
Career Highlights
Throughout her career, Wendy has worked with notable companies such as Celtrix Pharmaceuticals, Inc. and Genzyme Corporation. Her experience in these organizations has contributed to her expertise in the field of biotechnology and antibody development.
Collaborations
Wendy has collaborated with esteemed colleagues, including James R Dasch and Doran R Pace, III. These partnerships have further enhanced her innovative work in the biotechnology sector.
Conclusion
Wendy O Waegell's contributions to the field of biotechnology, particularly in the development of monoclonal antibodies, highlight her role as a leading inventor. Her work continues to impact therapeutic applications and advance scientific knowledge.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile